Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis [0.03%]
随机对照试验：tenofovir-emtricitabine和lopinavir-ritonavir联合抗逆转录病毒疗法在原发性胆汁性胆管炎患者中的应用
Ellina Lytvyak,Ishwar Hosamani,Aldo J Montano-Loza et al.
Ellina Lytvyak et al.
Background: Prior studies using reverse transcriptase inhibitors to treat a human betaretrovirus (HBRV) in patients with primary biliary cholangitis (PBC) resulted in a 21% reduction in alkaline phosphatase (ALP). Herein,...